breast
cancer
one
common
cancer
women
around
world
highli
heterogen
diseas
decad
divid
sever
subgroup
accord
immunohistochem
stain
ihc
three
receptor
estrogen
receptor
er
progesteron
receptor
pr
epiderm
growth
factor
receptor
tripleneg
breast
cancer
tnbc
defin
lack
express
er
pr
account
breast
cancer
character
enhanc
invas
metastat
capac
young
age
onset
poor
prognosi
howev
even
within
tnbc
patient
distinct
respons
treatment
prognosi
observ
develop
molecular
profil
four
six
distinct
subtyp
defin
within
tnbc
basallik
claudinlow
investig
make
effort
explor
novel
biomark
clarifi
characterist
tnbc
claudin
cldn
key
cell
adhes
molecul
compos
tight
junction
tj
regul
paracellular
permeabl
maintain
cell
polar
member
cldn
famili
member
predict
possess
four
transmembran
domain
intracellular
amino
carboxyltermini
cytoplasm
two
extracellular
loop
report
express
level
decreas
breast
cancer
colorect
carcinoma
glioblastoma
melanoma
brain
metastasi
contrast
literatur
report
polymorph
cldn
gene
role
cancer
develop
studi
design
explor
relationship
genet
variant
clinicopatholog
characterist
surviv
tnbc
januari
decemb
patient
stage
primari
tnbc
accord
american
join
committe
cancer
classif
includ
studi
er
pr
statu
evalu
accord
guidelin
issu
american
societi
clinic
oncolog
asco
colleg
american
pathologist
cap
tumor
neg
er
pr
defin
tnbc
clinic
data
age
tumor
size
region
lymph
node
statu
histopatholog
grade
vascular
invas
collect
followup
visit
perform
everi
month
year
everi
month
year
annual
patient
follow
decemb
collect
data
recurr
death
investig
approv
institut
review
board
chines
academi
medic
scienc
cancer
hospit
jiangxi
cancer
hospit
conduct
accord
ethic
standard
declar
helsinki
follow
nation
intern
guidelin
written
inform
consent
obtain
patient
peripher
blood
sampl
ml
collect
patient
upon
recruit
store
dna
extract
genotyp
data
gene
region
encompass
kb
upstream
kb
downstream
flank
sequenc
extract
hapmap
chines
han
popul
haploview
softwar
use
identifi
tag
singl
nucleotid
polymorph
snp
inclus
criteria
snp
known
ethnic
han
chines
popul
minor
allel
frequenc
maf
total
five
candid
snp
select
genotyp
tabl
primer
probe
design
massarray
typer
softwar
massarray
malditof
system
sequenom
inc
san
diego
ca
usa
use
genotyp
method
describ
sequenom
genotyp
protocol
statist
analysi
perform
use
spss
version
spss
inc
chicago
il
usa
distribut
genotyp
patient
differ
clinicopatholog
characterist
compar
twosid
pearson
test
odd
ratio
or
confid
interv
ci
calcul
logist
regress
diseasefre
surviv
df
calcul
date
diagnosi
date
first
locoregion
recurr
first
distant
metastasi
death
caus
whichev
came
first
overal
surviv
os
calcul
date
diagnosi
date
death
reason
last
followup
curv
logrank
test
appli
estim
compar
df
os
rate
patient
differ
genotyp
hazard
ratio
hr
recurrencemetastasi
death
ci
estim
coxregress
model
multivari
analysi
adjust
age
histolog
grade
tumor
size
lymph
node
statu
vascular
invas
statist
test
twosid
p
consid
signific
total
tnbc
patient
enrol
studi
median
age
diagnosi
year
old
rang
os
df
rate
respect
patient
year
old
grade
tumor
subject
diagnos
stage
ii
iii
associ
clinicopatholog
characterist
surviv
list
tabl
patient
grade
tumor
significantli
poorer
os
rate
grade
tumor
vs
hr
ci
tumor
size
lymph
node
statu
significantli
associ
df
os
signific
associ
age
vascular
invas
tnbc
surviv
multivari
analysi
tumor
size
hr
ci
lymph
node
statu
p
hr
ci
demonstr
independ
prognost
factor
interact
genotyp
variou
clinicopatholog
characterist
summar
supplementari
tabl
distribut
genotyp
significantli
associ
age
grade
tabl
ga
genotyp
associ
older
age
hr
ci
aa
genotyp
hr
ci
carrier
like
develop
grade
tumor
genotyp
also
relat
grade
patient
grade
tumor
cc
genotyp
carrier
hr
ci
signific
associ
genet
variant
clinicopatholog
featur
tabl
list
df
os
rate
patient
differ
genotyp
associ
polymorph
surviv
tnbc
patient
tt
genotyp
carrier
less
df
rate
cc
genotyp
carrier
df
respect
howev
differ
signific
pvalu
univari
multivari
analys
respect
sinc
ten
patient
carri
tt
genotyp
result
need
verifi
principl
function
tj
includ
prevent
mix
membran
protein
apic
basolater
membran
control
paracellular
passag
ion
solut
cell
tj
play
import
role
tumor
progress
metastasi
disrupt
tj
tumorigenesi
gener
lead
invas
loss
cohes
lack
differenti
cancer
cell
cldn
first
compon
identifi
involv
seal
tj
date
cldn
famili
member
identifi
cldn
differ
tissueexpress
pattern
function
thu
cldn
may
serv
biomark
detect
cancer
possibl
target
cancer
therapeut
one
commonli
investig
cldn
associ
polymorph
tnbc
never
report
kb
gene
code
kb
transcript
translat
import
protein
report
polymorph
associ
risk
cancer
small
vessel
vascular
dementia
leukoaraiosi
hepat
c
viru
infect
v
studi
found
genotyp
relat
risk
colon
cancer
polymorph
associ
differenti
age
colon
cancer
chen
et
al
report
polymorph
significantli
associ
decreas
suscept
colorect
cancer
chines
popul
polymorph
investig
studi
never
report
cancer
patient
first
demonstr
genotyp
significantli
associ
age
grade
tnbc
patient
age
differenti
prove
prognost
factor
breast
cancer
result
indic
potenti
role
polymorph
biomark
tumor
invas
prognosi
though
research
polymorph
rare
protein
wide
investig
cancer
promot
suppress
tumor
prolifer
differ
cancer
even
differ
histolog
subtyp
cancer
express
report
increas
cell
invas
colorect
cancer
oral
squamou
cell
carcinoma
oscc
long
consid
tumor
suppressor
breast
cancer
recent
studi
show
express
level
low
luminallik
claudinlow
breast
cancer
express
level
high
basallik
er
neg
medullari
breast
cancer
whether
play
tumorfacilit
role
basallik
breast
cancer
tnbc
still
need
prove
downregul
associ
shorter
df
breast
cancer
patient
tnbc
phenotyp
also
predict
poor
prognosi
studi
associ
polymorph
surviv
tnbc
patient
observ
explan
first
sampl
size
rel
small
subgroup
analysi
second
though
polymorph
might
influenc
express
level
protein
complex
interact
cldn
famili
member
could
also
affect
result
use
string
found
interact
protein
cldn
famili
figur
cldn
express
could
clinic
use
predict
surviv
erneg
subgroup
patient
breast
cancer
high
express
confer
chemoresist
breast
cancer
combin
analysi
relat
protein
might
help
us
better
understand
role
tnbc
express
level
found
associ
tumor
differenti
age
sever
kind
cancer
oscc
highest
express
observ
welldifferenti
oscc
wherea
poorli
differenti
oscc
exhibit
mostli
neg
stain
hepatocellular
cancer
downregul
associ
poor
differenti
basallik
breast
cancer
patient
highest
level
protein
express
observ
patient
older
year
age
assum
polymorph
might
influenc
express
level
protein
influenc
tumor
differenti
howev
underli
mechan
need
investig
result
also
suggest
polymorph
might
help
us
identifi
subtyp
tnbc
tnbc
patient
differ
age
grade
prove
uniqu
molecular
featur
conclus
first
demonstr
polymorph
gene
associ
age
differenti
tnbc
patient
sinc
polymorph
never
report
underli
mechan
still
unknown
research
need
verifi
result
